Skin cancer, a major public health issue

The incidence of both non-melanoma and melanoma skin cancers has been multiplied by more than three between 1980 and 2005. . Currently, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and according to the Skin Cancer Foundation Statistics, one in every five Americans and one in three Australians will develop skin cancer in their lifetime.

The overall 5-year survival rate for patients whose melanoma is detected early, before the tumor has spread to regional lymph nodes or other organs, is about 98%. The survival rate falls to 63% when the disease reaches the lymph nodes, and 16% when the disease metastasizes to distant organs.

A new look under your skin

DAMAE Medical has developed a medical device providing dermatologists a new in vivo imaging technique capable of producing images similar to histology images without the need for skin tissue excision and processing.

Without any sample of the anomaly, the physician would be able to detect a skin disease before it has any effect at the surface.


Our actualities


Laureate of the EDF pulse price
edf-pulse-sante-et-electricite

After 8 month of competition, DAMAE Medical had been given the health category award of the “prix EDF Pulse”. During this second edition, 240.000 votes had been collected. Thanks to every body, this is the beginning of a great adventure !

winner of the world innovation competition
Le président Hollande félicite Anaïs

DAMAE Medical has been rewarded by the French Innovation 2030 Commission, being one of the winners of the Worldwide Innovation Challenge in the category “Individualized Medecine”.
On July 13th 2014, Anaïs Barut and David Siret, cofounders of DAMAE Medical had the honor of
being welcomed at the french Palais de L’Elysée, in order to present their company in front of
the President, Mr. François Hollande, many Ministers and the Head of the Innovation 2030 Commission, Mrs. Anne Lauvergeon.

the team and its partners
equipe-fondateurs-employes

Since January 2013, the three fondators of DAMAE Medical have been specializing in their own accountabilities, in order to constitute a pluridisciplinar, coherent and complementary leading team. To achieve the integration of the DAMAE devices in the medical sector, the leading team is regularly advised and guided by partners from several fields of skill.